JPS5925762A - Self-guide type cathetel - Google Patents
Self-guide type cathetelInfo
- Publication number
- JPS5925762A JPS5925762A JP57134008A JP13400882A JPS5925762A JP S5925762 A JPS5925762 A JP S5925762A JP 57134008 A JP57134008 A JP 57134008A JP 13400882 A JP13400882 A JP 13400882A JP S5925762 A JPS5925762 A JP S5925762A
- Authority
- JP
- Japan
- Prior art keywords
- catheter
- hollow
- self
- monofilament
- bulb
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Media Introduction/Drainage Providing Device (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
この発明は、血管内の患部の状態検査または治療を行な
うために使用するガイドワイヤとカテーテルの役目を兼
備した自己ガイド型カテーテルに関する本のである。さ
らに詳しくは、この発明は、操作性がすぐれ、患者に与
える苦痛が軽減され、しかも超選択的な血管内患部の治
療が可能な自己ガイド型カテーテルに関するものである
。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a self-guided catheter that functions as both a guide wire and a catheter for use in inspecting or treating the condition of an affected area within a blood vessel. More specifically, the present invention relates to a self-guided catheter that has excellent operability, reduces patient pain, and is capable of ultra-selective treatment of affected areas within blood vessels.
人体の血管内に発生した患部の状態検査やその患部に薬
液を輸送するために使用するカテーテルは、従来、あら
かじめ血管内へガイドワイヤを送り込み、その外壁面に
沼って患部へと導入されるようになっていた。この目的
のために使用されているガイドワイヤは、例えば米国C
00K社、 UMI社、 USCI社などから製造販売
されているコイル状金属線であり−これらはステンレス
スティール線およびステンレススティール線コイルから
構成ぶれている。他方、カテーテ°ルは−例えば米国U
Ml 社、 ECC社、 USCI社などから製造販売
されている合成樹脂製チューブであり、これらは上記の
金属製ガイドワイヤと組合せて用いられる。Conventionally, catheters used to examine the condition of diseased areas within the blood vessels of the human body and to transport medicinal solutions to the affected areas have been introduced by first sending a guide wire into the blood vessel, then swamping the outer wall of the catheter and introducing it into the affected area. It was like that. Guidewires used for this purpose are e.g.
These coiled metal wires are manufactured and sold by companies such as 00K, UMI, and USCI, and consist of stainless steel wire and stainless steel wire coils. On the other hand, catheters - e.g.
These are synthetic resin tubes manufactured and sold by companies such as Ml, ECC, and USCI, and are used in combination with the metal guidewires mentioned above.
」二d己金属虐ガイドワイヤとカテーテルを実際にIす
(III ’i−る1箱合にυよ、まずガイドワイ−V
を血管内に挿入12、こJlが目的の患部に到達し/こ
ら、ガイド′ツイヤを中子上1.−〔これを被覆rるよ
うな形で力1−−−デルを;、Q、人し、患部−\到達
さWた後、ガイド1′ツイヤ紫抜き出1〜、次いCカテ
ーテルの端部より治療液を注入l〜患部へ導入するよう
にする。この一連の操作においては、金属製フッ°イド
ワイヤは表向にコイル線!侍有の凹凸があるため面枠が
付着して・すいこと、ワイヤが金ル4製ご11す1いた
め、血管内、す1部まCガイドワイヤを送り込Ir用今
に極めて複ゼ(な]jI作手j幀や高度なデクニックを
必要とし、操IF u’Z 鮫fる時間も長いこと、お
↓び金属線であるため、ガイド′ツイヤを先進さピ゛る
に際し、血管内j(−*をlj41hhしたり、血管内
朦[にもぐり込んだりし\°tいCとなどの問題が生じ
ていた。これを実際に便用する鳴合、ガイドワイヤf/
1r11管内の目的とJ−る患部に先進させることがき
わめC困難なゎざCあり−しかも治療中の患者に力える
謔痛あるいシ1負世が入−きい。他方、カテーフールを
導入する際にii−カテーテル自体がガイドワイヤより
も太いため、患者に与える負担がさI′)に大きく−シ
かもガイドワイヤが先行して到達した個所捷でカテーテ
ルの先端を到達させることが困難で、この傾向は末梢血
管になるほど著し7い。全体とし−〔みても。``In order to actually insert the metal guide wire and catheter (III), first insert the guide wire and catheter.
Insert 12 into the blood vessel, and when it reaches the target affected area, insert the guide 12 over the core. - [Apply force 1 in such a way as to cover the area; Q. After reaching the affected area, guide 1' pull out the violet 1~, then C the end of the catheter. The treatment liquid should be introduced into the affected area from the injection point. In this series of operations, the metal hood wire is a coiled wire! Due to the unevenness of the irradiation, the face frame adheres to the wire, and the wire is made of metal 4. Therefore, it is extremely difficult to insert the C guidewire into the blood vessel and into the 1st part of the blood vessel. ] Requires manual handling and advanced techniques, takes a long time to operate the guide, and since it is made of metal wire, it is difficult to insert into the blood vessel when advancing the guide. (There were problems such as the -* being lj41hh or getting into the blood vessel.
There are situations in which it is extremely difficult to advance the treatment to the affected area for the purpose of intravenous treatment.Moreover, it can cause pain and negative effects on the patient during treatment. On the other hand, when introducing the catheter, the burden placed on the patient is greater because the catheter itself is thicker than the guide wire. This tendency is more pronounced in peripheral blood vessels. As a whole - [even looking at it].
この方式による操作りよ〜ガイドワイヤの導入、カテー
テルの導入、ガイドワイヤの引き抜き、薬液の注入等の
多くの手順を要するばかりか、種々の形状を有する複数
のガイドワイヤやカテーテルを組み合け゛て用いる鳴合
が多いため、操作に長時間を要し、目的とする患部血管
−\カテーテルを超選択的に到達させることが極めて困
難であるといつ欠点を持つ。Operation using this method not only requires many steps such as introducing a guide wire, introducing a catheter, withdrawing the guide wire, and injecting a drug solution, but also involves combining multiple guide wires and catheters with various shapes. There are disadvantages in that the operation requires a long time because of the large number of calls, and it is extremely difficult to superselectively reach the target affected blood vessel with the catheter.
したがって、従来の金属製ガイドワイヤVとカテーテル
の組合せでは、冠状動脈等を含む末梢IIL ’tl内
膜を損傷する危険性が大きく、狭−V部やその末梢にま
で金目製ガイドワイヤを挿入することVま不可能であり
、そのため、たとえば・(〕筋梗塞症などで冠状動脈狭
Σγをきたした症例の場合[+−,1、開胸手術下に大
動脈と冠状動脈にバイパス全役けるといりた外科的手段
により治療を行りつしかないが、これCつの治療法は患
者の負担が大きく、多大な費用と時間を帰する。Therefore, with the combination of a conventional metal guide wire V and a catheter, there is a high risk of damaging the peripheral IIL'tl intima including the coronary artery, and it is difficult to insert the metal guide wire into the narrow V or its periphery. Therefore, for example, in cases where coronary artery stenosis Σγ occurs due to myocardial infarction, etc. [+-, 1, if a complete bypass is performed on the aorta and coronary artery during open-heart surgery, The only option is to use advanced surgical methods to treat the condition, but these three treatments place a heavy burden on the patient and result in a great deal of cost and time.
そこで−発明者らは一上記)「1〜ガイドワイヤ金用い
たカテーテル技術の欠点全改良すべく鋭意検討した結果
、中空構造を有する合成樹脂製モノフィラメント・を素
lとし−これに特定の構造を与えてガイドワイヤとカテ
ーテルの役割を兼備させることにより、容易な操作C従
来到達し得なかった末梢血管の患部にまで超選択的に挿
入することがI可能で、1・V!作件の(祇めですぐれ
た自己ガイド型カテーテルが得られることを見出し、こ
の発明に到達した。Therefore, the inventors conducted intensive studies to improve all the shortcomings of the catheter technology using guide wires (see above), and found that a synthetic resin monofilament with a hollow structure was used as a base material, and a specific structure was added to it. By combining the roles of a guide wire and a catheter, it is possible to super-selectively insert the peripheral blood vessel into the affected area of the peripheral blood vessel, which was previously impossible to reach, with easy operation. The inventors discovered that an excellent self-guide catheter can be obtained using a simple method, and arrived at this invention.
一ツなわら、この発明は、合成樹脂製中空モノフィラメ
ントの先端部を端から順に球部、フレキシブル部お上び
デーパ部に構成するとともに、テーパ部以降の部分を操
作部に構成し、球部に薬液導Ill lj k:、ま/
こi・■浮部後端しこ薬KL (IE人口をそれぞ〕L
設し)るとともに−球部の中空部には、フレキシブル部
内ヴ)借所fイニ薬液、’7(、出11に連通さVる空
所を作るための欠所がモノフィラメントの長さ方向に清
い形成されたレントゲン線不透過金属の小片をへまたそ
の余の部分のうち少なくとも操作部の中空部には、薬液
注入口をテーバ部内の空所しこ連通させるに必要な空所
を確保させるに足る断面を持つレントゲン線不透過金属
線条をそ)1.ぞれ内蔵させ、モノフィラメントの全長
にわたって連通ずる空所を薬液輸送路としたことを特徴
とする自己ガイド型カテーテルをその要旨とする。However, in this invention, the distal end of a hollow monofilament made of synthetic resin is configured in order from the end into a spherical part, a flexible part, and a tapered part, and the part after the tapered part is configured as an operating part, and the spherical part Ill lj k:、Ma/
Koi・■ floating part posterior end injection KL (IE population respectively) L
- At the same time, in the hollow part of the bulb, there is a cutout in the length direction of the monofilament to create a cavity that communicates with the flexible part. A small piece of X-ray opaque metal that has been formed cleanly is cut into a hole, and at least in the remaining part of the hollow part of the operation part, a space necessary for communicating the chemical solution inlet with the space in the taper part is secured. 1. The gist of the catheter is a self-guided catheter characterized in that a cavity communicating with the monofilament over its entire length is used as a drug liquid transport path.
つぎに、この発明にかかる自己ガイド型カテーテルの構
造につき、実施例を挙げて説明する。第1図G)は実施
例にかかる自己ガイド型カテーテルの基本構造を示す縦
断面図、第1図(b)は第1図(a)のA−A線での横
断面図である。このカテーテルは、全長にわたって連通
する中空部分2を有する合成It 1llli製モノフ
イラメントlk素材とし、そQ)先端部を1Mから)1
v(に球部3.フレキ−7プル部4およびテーバ部5に
構成するとともに−チー・Z部5以降の部分全体全操作
部6に構成している。球部3の先端には薬液導出ロアが
開L1さり、、」・v1作部6の後端間(」部は薬液注
入口8となっている。Next, the structure of the self-guide catheter according to the present invention will be explained by giving examples. FIG. 1G) is a longitudinal cross-sectional view showing the basic structure of the self-guided catheter according to the embodiment, and FIG. 1(b) is a cross-sectional view taken along line A--A in FIG. 1(a). The catheter is made of a synthetic Itlli monofilament LK material with a hollow part 2 communicating over its entire length, with a distal end ranging from 1M to 1M.
V (is configured in the ball part 3, flexible 7 pull part 4 and taper part 5, and the entire operation part 6 from the Qi/Z part 5 onwards.The tip of the ball part 3 has a chemical liquid outlet. The lower part opens L1, and the part between the rear ends of the v1 working part 6 is the chemical liquid inlet 8.
球部3は、この実施例でtま先端が球面となった円筒状
Cあるが、Zz球状であ−)てもよく、長球状であって
もよい。薬液導出Ll 7 Itよ球部3の側面に設け
られるとともある。薬液導11−目−17は、液のたま
りを少なくするため、外ひろがりのテーパ状に開L1さ
ハ、Lいることが好ましい。球部3の中空部にン、1−
第2図にもみるように、レントゲン線不透過金属からな
る円筒形の小片9が内蔵σf′シてbる。In this embodiment, the spherical portion 3 has a cylindrical shape with a spherical tip, but it may also be spherical or elongated. It is said that the chemical solution lead-out Ll 7 It is provided on the side surface of the bulb part 3. In order to reduce the accumulation of liquid, it is preferable that the chemical liquid guide 11-17 is opened in a tapered shape extending outward. In the hollow part of the bulb part 3, 1-
As shown in FIG. 2, a small cylindrical piece 9 made of an X-ray opaque metal is built-in σf'.
小片9内に形成さノ1−だ、モノフィラメントlの長さ
方向に?15つ欠所すなわら断面円形の長孔1oは、フ
1/−X−シフル部4内の空所1.1を71i’G液>
q出ロアに連通さくiでいる。球部3には、第3図に示
されている。t′)な小片12が内メ−4されでいても
よい。この小片12し」−中心から半径方向に延びる三
つの壁を持ら、名壁間には、モノフィラメント1の長さ
方向に活う欠所すなわら断面玉角jヒの長rM 13が
形成さノし乙いる。長溝13は、セーリーフレキシブル
76B 4内の空所11を薬I夜冴11目−17Vc連
通さVこいる。この上うな小片12が内蔵されている場
合は、第4図に示さitでいるようしこ一球部3の側面
に薬液導出[」7を設けることができる。球部3に内蔵
させる小片をよ、薬液導出1]をフレキンゲル部内の空
所に連通させることができるものであれば、その形状、
構造は上記のごときものでなくてもよい。例えば、多数
の連通孔を有する多孔質のものであってもよく、極細線
を束ねたような本のであってもよい。しかし、第2図に
例示され一〇いるような球部3に平行な中空構造および
/−!たをユ第3.4図に例示されているような球部3
に平行な外固溝付措造を有しでいる小片1ま、このよう
な条件を満足しない単なる小片、例えば棒状体に比し、
薬液のスムースな導出を良好とさ亡る上でより好ましい
。レントゲン線不透過金属の小片は、球部が超選択的に
末梢血管患部へ到達したことを体外からモニターで観察
、確認す−るために十分なレントゲン線不透過性を有し
でいることが必殻であり−とくにレントゲン線不透過性
のすぐizた金。Formed within the small piece 9, along the length of the monofilament l? The 15 holes, that is, the long holes 1o with a circular cross section, fill the voids 1.1 in the f1/-X-shuffle part 4 with 71i'G liquid>
It is connected to the lower part of the q output. The bulb 3 is shown in FIG. t') small piece 12 may be internally molded. This small piece 12 has three walls extending in the radial direction from the center, and between the walls, a defect extending in the length direction of the monofilament 1, that is, the length rM 13 of the cross-sectional bead angle j, is formed. There is Sanoshioto. The long groove 13 communicates with the void 11 in the saily flexible 76B4. If the upper small piece 12 is built-in, a chemical solution outlet 7 can be provided on the side surface of the small ball part 3 as shown in FIG. The shape of the small piece to be built into the bulb part 3, as long as it allows the chemical solution outlet 1] to be communicated with the cavity in the flexible gel part,
The structure does not have to be as described above. For example, it may be porous with a large number of communicating holes, or it may be a book made of bundled ultra-thin wires. However, the hollow structure parallel to the sphere 3 and /-! The ball part 3 as illustrated in Figure 3.4
A small piece 1 which has an outer hard grooved structure parallel to the .
This is more preferable in terms of ensuring smooth delivery of the drug solution. The small piece of X-ray opaque metal must have sufficient X-ray opacity to monitor and confirm from outside the body that the bulb has superselectively reached the affected area of the peripheral blood vessel. Gold is a must-have, especially since it is radiopaque.
タングステン、白金、プラチナ卦1びスアンレスステイ
ールなどの累月が好ましく使用さノ]6る。Preferably used are tungsten, platinum, platinum hexagon 1, and stainless steel.
フレキノプル部4Vi中空の(++にめ−C細くしなや
かな部分C′あり、かつ十分な強度を備えている。Flexinople part 4Vi has a hollow (++ narrow and flexible part C') and has sufficient strength.
デーパ、・IIへ5を、1−そのIG径が(・ψ浮部6
に向かうにしたが□、1人きくなり一操浮部6に至った
ところで操作部6と同じ直径となるよ・′〕デーパ状に
加工さノ1てトリ、Mλ1.〈tまその中空部σ)−・
部にレントゲン紳f’til過金属p’41条を内蔵し
ているε−とである。Depah, ・5 to II, 1 - its IG diameter is (・ψ floating part 6
□, I was alone and when I reached the floating part 6, it had the same diameter as the operating part 6. <tmaso hollow part σ)−・
It is ε-, which has a built-in X-ray metal f'til permetallic p'41 strip in the part.
」・”φ作iiRh il、、中ご、゛コ七ノノイラメ
ノトlの構造そのもG)をノーGA・構造とし−C持1
)、−そL/)yl、は全長に巨る中空部分2K、レン
トゲン線不透過金属線条14を内蔵しているが−この金
属線条14の直径は中空部分2の中空径(内径)よりも
小さな直径、とくに中空部の20〜80幅の直径を有す
るのがtイ+E Lい。金属線状14は、このように操
作部6の中空径より小さな直f看の断面を有するため、
薬液注入ロ8奈テーバ部5内の空所15に連通さ吐るに
必91 ft空所16を操作部6内に確保させている。”・”φ made ii Rh il,, inside, the structure of ゛Konanonoiramenoto l is also G) as a no GA structure - C holding 1
), -soL/)yl, has a large hollow part 2K over its entire length and a built-in X-ray opaque metal filament 14, but the diameter of this metal filament 14 is the hollow diameter (inner diameter) of the hollow part 2. It is preferable to have a diameter smaller than that, especially a diameter of 20 to 80 mm in the hollow part. Since the metal wire 14 thus has a cross section with diameter f smaller than the hollow diameter of the operating portion 6,
A 91 ft space 16 is ensured in the operation part 6 to communicate with the space 15 in the tapered part 5 of the drug injection hole 8 and to discharge it.
こび)↓゛)ろ:空所を確保さIjる構造の線条として
は、中梁状線条マ゛連通孔を持つ多孔質線条もしくは極
#lll線の東状体などがあり適宜に採用さitでよい
。KOBI)↓゛)RO: The striations with a structure that secures a void space include a medium-beam-like striation, a porous striation with a communicating hole, or an east-shaped body of a polar #llll wire, etc. It is fine if it is adopted.
なお、ここで用いるレントゲン線不透過金属線条とは、
ステンレススティール、タングステンなどに代表される
レントゲン線照射による造影力のすぐれた金属の線条で
あり、これらtま使用する薬液との反応性を考慮して、
通常ポリエチレン、ポリエチレンテレフタレートおよび
フッ素1]ffJII旨などの樹脂でコーティングして
用いるのが好ましい。The X-ray opaque metal filament used here is
These metal strips, such as stainless steel and tungsten, have excellent contrast properties when irradiated with X-rays, and in consideration of their reactivity with the chemical solutions used,
Usually, it is preferable to use it by coating it with a resin such as polyethylene, polyethylene terephthalate, and fluorine 1]ffJII.
またレントゲン線不透過金属線条の先端方向Vま、第1
図に示したように先鋭状にテーバ加工され−Cいること
が好−ましく、これによりカテーテルの操作性や薬液の
供給性が一層向−ヒする。In addition, the tip direction V of the X-ray opaque metal filament is
As shown in the figure, it is preferable that the catheter be tapered into a sharp point, which further improves the operability of the catheter and the ability to supply the drug solution.
金属線状14は、例えば次のようにして固定されるのが
よい。すなわち、金属線状14の後端を操作部6の後端
間1」部におい−C外側に折り曲げ一第1図のようにチ
ューブ17などをかぶせ−〔−固定するのである。金属
線条14の固定が不冗全であると、薬液注入時に一金属
線状14が先端方向へずれ、薬液の導入がしゃ断される
ことになるた−め好ましくない。なお、薬液注入り、l
Hに&i〜通贋キャップがかぶせられ、第1図の1つ
しこさらにコ才、フタ−18が設けらり、(、注射器等
と接続できる構造に+1“り成される。The metal wire 14 is preferably fixed in the following manner, for example. That is, the rear end of the metal wire 14 is bent outward at the 1'' portion between the rear ends of the operating section 6, and then covered with a tube 17 or the like as shown in FIG. 1 and fixed. If the metal wire 14 is not fixed redundantly, the metal wire 14 will shift toward the distal end during injection of the chemical solution, which is undesirable because the introduction of the chemical solution will be cut off. In addition, chemical injection, l
A pass cap is placed on H, and a cover 18 is provided in addition to the cap shown in FIG.
と−のようにし−C2カデーテル内C+i、薬l夜注入
[18から薬n1導出ロアまでの間−操作部6内の空所
16.テーバ部5内の空所15.フレキシブル!IL
A内の空所11および球部3内の空所(欠所1゜+ #
&:1.’ 13 )かモノフィラメントの全長にわた
っ(il扛j(>−fる窒所全つくり、この連通空所が
この自己ガイド型カテーテルの薬り、輸送路となる。薬
液翰送路にt、12、通常−滅l爽処理が施されている
。- As shown in the figure - C+i in the C2 catheter, drug l night injection [18 to drug n1 delivery lower - empty space 16 in the operating section 6. Vacant space 15 in the taber section 5. flexible! IL
Vacant space 11 in A and void space in bulb 3 (missing space 1° + #
&:1. '13) or over the entire length of the monofilament (il 扛j(>-f)), this communicating space becomes the drug delivery and transport route for this self-guided catheter. , usually subjected to a sterilizing treatment.
カブーーテル各部の寸法については、治療患者の年令、
1ト質あもいl−1患部の人+e1などの条rトrこよ
り左右、x〕1−るl杜めとくに制限1tJ、 l、
fr−贋が、通常の代・翳的な各部の寸法を例示t−れ
は次のとおりである。Regarding the dimensions of each part of the cabootel, please refer to the age of the patient being treated,
1 to the left and right from the affected area person + e1, etc.,
Examples of the dimensions of each part of the normal replacement and shadow are as follows.
ナオ、テーパ部の直径は、フレキシブル部から操作部へ
かけて徐々に太くなるものであるため具体的な数値とし
てVま示していない。また、フレキシブル部とテーパ部
の長さが必らずしも明確に区別できない場合もあるが、
フレキシブル部とテーパ部の長さの合計を200 mm
以内にするのが適当である。モノフィラメントの中空部
分の内径は太いほど好ましい。Note that the diameter of the tapered portion gradually becomes thicker from the flexible portion to the operating portion, so even V is not shown as a specific value. In addition, the lengths of the flexible part and the tapered part may not always be clearly distinguishable;
The total length of the flexible part and tapered part is 200 mm.
It is appropriate to keep it within the range. The larger the inner diameter of the hollow portion of the monofilament, the better.
この発明の自己ガイド型カテーテルを構成する合成樹脂
素材としては一浴融押出成形が可能な材料であね、げと
くに制限しないが、ポリアミド、ポリエステル、ポリオ
レフィンおよびフッ素tIJ脂などが好ましく使用でき
る。The synthetic resin material constituting the self-guided catheter of the present invention must be a material that can be molded by one-bath melt extrusion, and preferably includes, but not limited to, polyamide, polyester, polyolefin, and fluorine tIJ resin.
この発明の自己ガイド型力テーデルを製造するに−は、
まず、中空口金を使用して一通浩の溶融紡糸法により中
空モノフィラメントを紡糸し−なお〜所望によりこれを
適宜延伸して、適当な長さに切断する。次に、上記の切
断17た中空モノフィラメントの先端部分について、球
部3の形成部を残して局部的な高倍率延伸を施し、フレ
キシブル部4とデーパ部5を一挙に作成(7た後、球部
形成部の中空部分しこ1/ノトゲン純不透](、儀金属
の小片9.12全挿入17、薬液導出ロアをりqすよつ
に半溶封して球i1’+ 3 rf影形成る。その後、
操作部6の後端から中空部分2にデーパ部5方向へ向け
てレントゲン線不透過金属
曲げて4;I≦e注入1.18近辺C固定す−る。、な
お、との際に;ノノトゲシ線不透過金属線条先端方向の
端部をfめブーバ状に加工1. fおくことが好ましく
、これによりさらに柔軟性9弾力性が伺与さJして操作
性が一段と向」ニする。また、球部を完全に溶封17た
禍合にV」1、球部3の外側から中空部分にかけて、+
1@4+1ドリルなどで小孔をうがら〜薬液導出ロアを
形[戊することができる。続いて、必要に応じ、薬液注
入118にギーYツブマ・コネクターなどの接続端J’
l 8i・形成または取り伺ける。こハ、に1り一こ(
ハ光明の自己ガイド型力デーデルが完成する。To manufacture the self-guided force Tedel of this invention,
First, a hollow monofilament is spun by a one-way melt spinning method using a hollow spinneret, and if desired, it is appropriately stretched and cut into a suitable length. Next, the tip part of the hollow monofilament cut 17 above is subjected to local high-magnification stretching, leaving the part where the spherical part 3 will be formed, to create the flexible part 4 and the tapered part 5 at once (after 7) The hollow part of the part forming part 1/notogen pure impermeability] (The small piece of metal 9.12 is fully inserted 17, and the chemical solution lead-out lower part is semi-melted and sealed to form a sphere i1'+ 3 RF shadow form.Then,
An X-ray opaque metal is bent from the rear end of the operating part 6 to the hollow part 2 in the direction of the tapered part 5 and fixed at a point C near 4; I≦e injection 1.18. , Incidentally, when doing this, the end of the non-transparent metal filament in the direction of the tip is processed into a bobber shape.1. It is preferable to leave it in place for a long time, as this provides further flexibility and elasticity, further improving operability. In addition, if the bulb is completely melt-sealed 17, V''1, from the outside of the bulb 3 to the hollow part, +
1@4+1 It is possible to drill a small hole with a drill etc. to form the chemical solution lead-out lower. Next, if necessary, connect the connection end J' of a ghee Y-tubuma connector etc. to the chemical injection 118.
l 8i・Can be formed or inspected. Koha, Niichi Riichiko (
Hakoming's self-guided power Dadel is completed.
frお、こ・7)カテーテルの外表面に、シリコーンコ
ーディングマ゛テフロンコーティングなどの抗血栓住処
1111j 5j、、施すばさらに好ましく、こり、に
より抗血栓性およびすべりに代表さiする操作性が−j
メ改良される。7) It is more preferable to apply an antithrombotic coating such as a silicone coated Teflon coating to the outer surface of the catheter, which improves antithrombotic properties and operability represented by slippage due to stiffness. j
The menu will be improved.
上記の構成からなるこの発明の自己ガイド型カテーテル
を使用する際は、これを血管内に挿入し、レントゲン線
投射による造影を監視しつつ−その先端を超選択的に目
的とする血梢血管患部へ到達させ−次いでその患部へ薬
液を導入する。When using the self-guided catheter of the present invention having the above-mentioned configuration, it is inserted into a blood vessel, and while monitoring contrast enhancement by X-ray projection, its tip is super-selectively targeted to the affected area of the peripheral blood vessel. - Then introduce the medicinal solution to the affected area.
この自己ガイド型カテーテルは、使用時に、次の如き効
果を発揮する。すなわち、最先端の球部3は、血管内で
血管に借って自由に動くことができ一血管内膜を損傷し
たり、内膜Fにもぐり込むことがないので、従来の金属
ガイドワイヤeの押込む操作に比べ、血管に沿わせた自
由な動きで血管中へ導入でき、無理のない自然な操作で
血管内膜を痛めることなく目的の患部−\到達させるこ
とができる。また、球部3d、レントゲン線不透過金属
の小片9,12を内蔵しているので、レノ)−ゲン線を
投射し、X線テ1/ビモニターr %h視しつつ作業す
る際、その位置を容易に確認することができ、目的とす
る患部へのみ薬/l!5f:ft人することt−可能と
さする。フレキンプル部4は、細く柔軟に設計されCい
るため、球部3の血管内に卦ける自由運動を−Ii4効
果的なものと[る。テーバ部5Q1、デーパ状に加工さ
れているため、血液の異常1″IW留が防止できるとと
もに、球部3を目的とする血管の人11・\導入する過
程での前進、後退などの微妙な操作を容易に行なわせる
ことができる。かかる横端の球部3.)1/ギンプル部
4卦よびテーパ部5からなる先端部分は、たとえば豆腐
にも突きささらない程度の柔軟性9弾力性を有している
のC11r1[管内膜の破壊や患者に対する苦痛を著し
く軽減することができる。また、操作部6は、合成11
°VJ 脂製モノフィラメントからI構成され−〔いる
ため、表向が滑らかで弾力性に富み、操作を容易とさI
する。また、全長にわたりレントゲン線不透過金回線条
14を内蔵しでいるのC、モニターを通じ−C写し出さ
)1.る影像を極め−C鮮明とさせる。This self-guided catheter exhibits the following effects when used. In other words, the most advanced bulb part 3 can move freely within the blood vessel, relying on the blood vessel, and does not damage the intima or penetrate into the intima F, which is different from the conventional metal guide wire e. Compared to a pushing operation, it can be introduced into a blood vessel by free movement along the blood vessel, and can be delivered to the target affected area with a natural and natural operation without damaging the vascular intima. In addition, since the bulb part 3d has built-in small pieces of metal 9 and 12 that are opaque to X-ray radiation, it is possible to project the rays and position them when working while viewing the X-ray beam. You can easily check the medicine/l only to the intended affected area! 5f: It is possible to do ft people. Since the flexible part 4 is designed to be thin and flexible, the free movement of the bulb part 3 within the blood vessel is effective. Since the tapered part 5Q1 is processed into a tapered shape, it can prevent abnormal 1" IW retention of blood, and also prevent subtle movements such as advancement and regression during the process of introducing the blood vessel aimed at the bulbous part 3. The operation can be easily performed.The tip portion consisting of the ball portion 3.) 1/gimple portion 4 and the tapered portion 5 at the side end has flexibility 9 elasticity to the extent that it does not pierce even tofu, for example. C11r1 [can significantly reduce the destruction of the intima and the pain to the patient.
°VJ Constructed from resin monofilament, it has a smooth surface and high elasticity, making it easy to operate.
do. In addition, it has a built-in X-ray opaque gold line 14 over its entire length, and is projected through the monitor)1. Makes the image extremely clear.
か<L7−U、この発明の自己ガイド型カテーテルを、
1、If+t ’iN (D Pi雑な走行や微妙な操
作に十分追従しC血讃内′\自山な動きで導入Cき−/
ことえげ血管の蛇行部分や超選択的な末梢血管へも容易
に挿入することができる。そして、カテーテルの先端を
目的の患部へ到達させた後、薬液注入[]8から薬液を
注入、圧送すれば、薬液は連通する空所からなる薬液輸
送路を通って薬液導出[コアかも患部へと効果的に供給
され、すぐれた治療効果を得させる。このカテーテルに
よれば、薬液は選択的に患部のみに導入されるので一少
縫の薬液で治療が達成でき、副作用などのおそれがない
。たとえば、制がん剤tよ正常部に対して副作用を及ぼ
すことが多く、一度に多くを投与することは不可能なば
かりか一患部から遠い部位より投与されるため、従来の
カテーテルによれば、希釈さね、その効能が十分行きわ
たらず、治療効果も必然的に低Fする。<L7-U, the self-guided catheter of this invention,
1. If + t 'iN (D Pi sufficiently follows rough driving and delicate operations, and introduces it with natural movements.)
It can be easily inserted into meandering parts of blood vessels and super-selective peripheral blood vessels. After the tip of the catheter reaches the target affected area, the drug solution is injected and pumped from the drug injection [] 8, and the drug solution is led out [the core may also be directed to the affected area] through the drug transport path consisting of a communicating cavity. and is effectively supplied to achieve excellent therapeutic effects. According to this catheter, the medicinal solution is selectively introduced only to the affected area, so treatment can be achieved with just a few stitches of the medicinal solution, and there is no risk of side effects. For example, anticancer drugs often have side effects on normal areas, and it is not only impossible to administer a large amount at once, but also to be administered from a site far from the affected area, so conventional catheters However, if it is diluted, its efficacy will not reach its full potential and the therapeutic effect will inevitably be low.
これに対し、この発明のカテーテルによれば、患部に直
接薬液を投与できるだめ、検力t」を必要最小限にとど
め一〇大きな治療効果を得ることができ、副作用のおそ
れ本全くない。On the other hand, according to the catheter of the present invention, since the medicinal solution can be administered directly to the affected area, it is possible to minimize the test force t' to the necessary minimum and obtain a large therapeutic effect, with no fear of side effects.
また、この発明の自己ガイド型)Jデーチルif −心
臓の冠状動脈等の超選択的造影への応用が可能(“、8
.す〜いわゆるコロナリー、カテーテ、としての適用が
期待できる。In addition, this invention can be applied to superselective imaging of the coronary arteries of the heart (self-guided type)
.. It can be expected to be applied as so-called coronaries and catheters.
1ユノ、上説、明した−[うに、への発明(1)自己ガ
イド型カデーブールは、−基でガイドワイヤとカテーテ
ルの役目を兼備するので、治療器具の省力化が達成C゛
き、かつ治療時間を著しく短縮させることがでへる。ま
た、そハ、自体杜1 < + RPVがあるため操作性
が極めC改善さね2、こバーまC到達Cきなかった超+
t4択的な血管内患部への挿入がH’iJ’能となる。Invention (1) Since the self-guided catheter functions as both a guide wire and a catheter, it is possible to achieve labor-saving treatment equipment, and Treatment time can be significantly shortened. Also, since there is a self-mori 1 < + RPV, the operability is extremely improved and C is improved 2, and I couldn't reach C at this point.
t4-selective intravascular insertion into the affected area becomes H'iJ' function.
し、か本−へ1ilj揮li脂製モノフィラメ−/トで
構成されているため、み而が渭らかで、抗血栓性であり
−また血管th jlシにあわす−C種々+7)形1(
に加−1こすると−とが’l’ fit: Cある。そ
の−ト、との発明に、しる自己ガイV)、1,1)カテ
ーテルは一通常の即1脈内”11′i置川カテーテル(
′(二比べCも十分細いだkj eなく、その内蔵する
金属WJIIにしり一適当f:r腰がイ」与さり、でい
るため、血r+Ii、l K、’ JHyt行L −U
1fll ′?′?内に留置する際げ、その位置が良
好1:(、jid持さJI、目的部位血管から脱落する
ことが−1v lもね−る。−9なわら、持続動脈内薬
液注入用+、、Y l”iカブ−−5’ルとして使用し
得る特性をも有するのである。However, since it is composed of a monofilamate made of volatile oil, it has a smooth texture and antithrombotic properties, and is suitable for blood vessels. (
If you add -1 and rub -, you get 'l' fit: C. According to the invention, the catheter is a conventional intravenous catheter (11'i Okikawa catheter).
'(Comparing the two, C is also thin enough kj e, and its built-in metal WJII gives a suitable f: r waist, so blood r + Ii, l K, ' JHyt row L -U
1fll'? ′? When indwelling the tube, its position is good 1: (JI, JI, there is no chance of it falling out of the target blood vessel. -9 However, for continuous intra-arterial drug injection +... It also has properties that allow it to be used as a Yl''i cube.
以下に具体的実施例を挙げて、この発明をさらに詳しく
説明する。The present invention will be explained in more detail with reference to specific examples below.
東しく株)製のポリエチレンテレフタレート(タイプ9
00)を素材とし、中空口金を用い−C5通常の溶融紡
糸法により、直径1. Otnmで、かつ中空孔径0.
7 mmの中空部分を有する未延伸中空モノフィラメン
トを紡糸し、これを1.3 mの長さに切断した。この
モノフィラメントの一端に球部形成部公約3 mmを残
t7て局部延伸装置イにより約3倍の延伸を施し一直径
0.4 mm 、長さ20 mmのフレキシブル部と
長さ110 mmのデーパ部を一9挙に作成した。次に
、先端部端より外径t)、 65 mm +中空径0.
4 mm 、長さ2 mmの金製中空デツプを挿入し
て加熱半溶封し一薬液導出11を有する先端球部を作成
した。他方、中空部分へ操作部後端から先端径Q、15
mm 、後端径0.255mm 、長さ1.3m
の先端テーバ付ステンレススティールH、’404番製
金属線条を挿入し、後端からt」み出た金属紳条端をl
ThTh外部外壁一つで約2 (l ynmおり曲げた
。Polyethylene terephthalate (Type 9) manufactured by Toshiku Co., Ltd.
00) was used as a material, and a diameter of 1. Otnm, and the hollow pore diameter is 0.
An undrawn hollow monofilament with a 7 mm hollow portion was spun and cut into 1.3 m lengths. At one end of this monofilament, a sphere-forming part of approximately 3 mm was left and stretched approximately 3 times using a local stretching device to form a flexible part with a diameter of 0.4 mm, a length of 20 mm, and a tapered part with a length of 110 mm. were created in one go. Next, the outer diameter t) from the tip end is 65 mm + hollow diameter 0.
A gold hollow dip having a diameter of 4 mm and a length of 2 mm was inserted and heated and semi-melt sealed to create a distal bulb having a chemical solution outlet 11. On the other hand, from the rear end of the operating part to the hollow part, the tip diameter Q, 15
mm, rear end diameter 0.255mm, length 1.3m
Insert the stainless steel H with a tapered tip and the '404 metal wire, and insert the end of the metal wire that protrudes from the rear end by l.
One ThTh external wall was bent by approximately 2 nm.
次いC1操作部後端に外径1.2 nHl(、内径1.
Omm +長さ1. Ommのポリ塩化ビニル111J
ナユープとアクリルベットV H型ルアロックコネクタ
ーを接、I剤(三共(株)?′Jアクリル系ハードロッ
クE510K)を介して一挙にとりつけ、金に線条の端
部を固定1、た。Next, at the rear end of the C1 operation part, an outer diameter of 1.2 nHl (and an inner diameter of 1.2 nHl) was attached.
Omm + length 1. Omm polyvinyl chloride 111J
Connect the Naup and Acrylic Bet V H type Lua lock connectors, attach them all at once via I agent (Sankyo Co., Ltd.?'J acrylic hard lock E510K), and fix the ends of the filaments to the gold.
以上の操作により第1図の構成分有する自己ガイl′型
カテーテルがイvられた。By the above operations, a self-guided L' type catheter having the components shown in FIG. 1 was completed.
(臨床例1)
実施inl f作成した自己ガイド型カテーテルを大部
動脈に経皮的に挿入し、大動脈を経て冠状動脈にカテー
テル先端を先進させ一臨床試験に供した。(Clinical Example 1) Implementation The prepared self-guided catheter was percutaneously inserted into the major artery, and the tip of the catheter was advanced into the coronary artery via the aorta for a clinical trial.
X線モニター・テレビ監視Fに球部の位置を確認りなが
ら冠状動脈末梢まC球部を進め、後端の薬液r−を人1
1に接続した薬液計;a J’#密ポンプで押圧す、ろ
ことにより、患部へ選択的に薬液を供給することかびき
た。While confirming the position of the bulb on the X-ray monitor/TV monitor F, advance the bulb C to the distal end of the coronary artery, and administer the drug solution r- at the posterior end to person 1.
The drug solution meter connected to 1;a J'# was used to selectively supply the drug solution to the affected area by pressing with a tight pump and using a filter.
この自己ガイド型カテーテルは、鈍な球部ときわめ−〔
柔軟ケフレキシブル部からなっており、それ自身が超選
択的ガイドワイヤの機能をもつため一目的とする患部ま
Cの挿入tま容易であった。さらに心臓自身を栄養する
重要な血管である冠状動脈内に挿入しても極めて安全で
あって、不整脈を起したり、血管内壁を傷つけることが
全くなかった。This self-guiding catheter has a blunt bulb and an extremely
It consists of a flexible part and has the function of a super-selective guide wire, so it is easy to insert it into the target affected area. Furthermore, it was extremely safe to insert into the coronary artery, which is an important blood vessel that nourishes the heart itself, and did not cause arrhythmia or damage the inner wall of the blood vessel.
したがって、この自己ガイド型カテーテルが冠状動脈末
梢あるいは閉塞性疾患に対する薬剤の冠iMb脈内選択
的投与、とくに持続投与に応用し得ることは明らかであ
る。Therefore, it is clear that this self-guided catheter can be applied to selective intravenous administration of coronary iMb, especially continuous administration, of drugs for peripheral coronary arteries or occlusive diseases.
さらに、この自己ガイド型カテーテルQま、x Ht2
投射によるモニター・テレビVC鮮明に映像さiLるの
で、一連の操作tま確実に安全に行なうことがCきた。Furthermore, this self-guided catheter Q, x Ht2
Since the monitor and television display a clear image by projection, a series of operations can be carried out reliably and safely.
また処理後のカテーテルの抜き出し操作本容易であった
。In addition, it was easy to remove the catheter after treatment.
(臨床例2)
実施例で作成した自己ガイド型カテーテルを肝細胞癌患
者の肝動脈内に超選択的に挿入し、持Hル11注を行な
°つた。(Clinical Example 2) The self-guided catheter prepared in Example was superselectively inserted into the hepatic artery of a patient with hepatocellular carcinoma, and 11 injections were performed.
すなわち、自己ガイド型カテーテルをあらかじめ超選択
的血管造影に上り特定しで釦いた[]的とする肝動脈末
梢まで挿入した後〜後端の薬液注入1」に接続した持続
注入ポンプ(クロノフユーザ−)により一制ガン剤マイ
トマイシン溶液t1時間あたりl meの割合で1週間
にわたり注入した。このカテーテルtま先端が鈍できわ
めで柔軟なフレキシブル部をもっており、それ自身が超
選択的ガイドワイヤの機能をもつため一目的とする肝動
脈末梢まCの超選択的挿入は容易Cあった。In other words, after inserting a self-guided catheter to the periphery of the hepatic artery, which has been identified in advance using superselective angiography, a continuous infusion pump (Kronoff User -), a mitomycin solution, an anticancer drug, was injected at a rate of 1 me per hour for 1 week. This catheter has a blunt tip and an extremely flexible portion, which itself functions as a super-selective guide wire, making it easy to super-selectively insert the catheter into the distal hepatic artery.
第1図(a) Vまこの発明の自己ガイド型カテーテル
の基本構造を示す縦断面図、第1図(b)&11部図(
3)のA−A線での横断面図Cある。第2図は第1図の
球部肝↓びその近傍部の拡大斜視図、第3図および第4
図Q」球部の別の態様例を示す拡大斜視図Cある。
■・・・不休(中空モノフィラメント) 2・・・中空
部分 3・・・球部 4・・・フレキシブル部5・・・
ンーー・8部 6・・・操作部 7・・・薬液導出11
8・・・薬fl¥ ?lE人119.12・・・小片1
()・・・長孔(欠所) 11・・・ノI/キシプル
部内の空所 13・・・溝(欠所) 14・・・金属線
条 15・・・テーパ部内の空所 16・・・操作部内
の空所Fig. 1(a) is a vertical cross-sectional view showing the basic structure of the self-guided catheter of the present invention, Fig. 1(b) & 11th part view (
There is a cross-sectional view C taken along line A-A of 3). Figure 2 is an enlarged perspective view of the bulbar liver ↓ and its vicinity in Figure 1, Figures 3 and 4.
Figure Q is an enlarged perspective view showing another embodiment of the bulb. ■...No breaks (hollow monofilament) 2...Hollow part 3...Spherical part 4...Flexible part 5...
8 parts 6...Operation part 7...Medical solution delivery 11
8...Medicine fl ¥? lE person 119.12...small piece 1
()...Elongated hole (defect) 11...Vacancy in the I/Xi pull part 13...Groove (defect) 14...Metal wire 15...Vacancy in the tapered part 16.・Empty space in the operation section
Claims (1)
端から順に球部、フレキシブル部およびテーバ部に構成
するとともに、テーパ部以降の部分を操作部に構成し、
球部に薬液導出口を、また操作部後端に薬液注入口をそ
れぞれ設けるとともに、球部の中空部には、フレキシブ
ル部内の空所を薬液導出口に連通させる空所を作るため
の欠所がモノフィラメントの長さ方向VCf5い形成さ
れたレントゲン線不透過金属の小片を、またその余の部
分のうら少なくとも操作部の中空部には、薬液注入口を
テーバ部内の空所に連通させるに必要な空所を確保させ
るに足る断面を持つレントゲン線不透過金属線条をそれ
ぞれ内蔵させ、モノフィラメントの全長にわたって連通
する空所を薬液輸送路としたことを特徴とする自己ガイ
ド型カテーテル。(1) The distal end of the synthetic resin hollow monofilament is formed into a spherical part, a flexible part, and a tapered part in order from the end, and the part after the tapered part is formed into an operating part,
A chemical liquid outlet is provided in the bulb and a chemical liquid inlet is provided at the rear end of the operation part, and a hollow part is provided in the hollow part of the bulb to create a cavity that connects the cavity in the flexible part to the chemical liquid outlet. A small piece of X-ray opaque metal is formed in the length direction VCf5 of the monofilament, and behind the remaining part, at least in the hollow part of the operating part, it is necessary to communicate the chemical solution inlet to the cavity in the taber part. A self-guide catheter characterized in that each of the X-ray opaque metal filaments with a cross section sufficient to secure a space is built-in, and the space communicating over the entire length of the monofilament is used as a drug liquid transport path.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57134008A JPS5925762A (en) | 1982-07-31 | 1982-07-31 | Self-guide type cathetel |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57134008A JPS5925762A (en) | 1982-07-31 | 1982-07-31 | Self-guide type cathetel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5925762A true JPS5925762A (en) | 1984-02-09 |
| JPH0232899B2 JPH0232899B2 (en) | 1990-07-24 |
Family
ID=15118218
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57134008A Granted JPS5925762A (en) | 1982-07-31 | 1982-07-31 | Self-guide type cathetel |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5925762A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0255963U (en) * | 1988-10-14 | 1990-04-23 | ||
| JPH02180277A (en) * | 1988-12-29 | 1990-07-13 | Terumo Corp | Guide wire |
| JP2008519220A (en) * | 2004-11-03 | 2008-06-05 | アクティブ・ショック・インコーポレイテッド | Electrically controlled pressure relief valve and system and method for controlling the pressure relief valve |
| WO2011081134A1 (en) * | 2009-12-28 | 2011-07-07 | テルモ株式会社 | Guide wire |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0532277U (en) * | 1991-10-09 | 1993-04-27 | ブリヂストンサイクル株式会社 | Infant vehicle |
| US6059771A (en) | 1996-12-23 | 2000-05-09 | Johnson & Johnson Medical, Inc. | Stiffening member to increase fluid flow within a medical device |
-
1982
- 1982-07-31 JP JP57134008A patent/JPS5925762A/en active Granted
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0255963U (en) * | 1988-10-14 | 1990-04-23 | ||
| JPH02180277A (en) * | 1988-12-29 | 1990-07-13 | Terumo Corp | Guide wire |
| JP2008519220A (en) * | 2004-11-03 | 2008-06-05 | アクティブ・ショック・インコーポレイテッド | Electrically controlled pressure relief valve and system and method for controlling the pressure relief valve |
| WO2011081134A1 (en) * | 2009-12-28 | 2011-07-07 | テルモ株式会社 | Guide wire |
| JP5451779B2 (en) * | 2009-12-28 | 2014-03-26 | テルモ株式会社 | Guide wire |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0232899B2 (en) | 1990-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hanafee et al. | Transjugular percutaneous cholangiography | |
| US6050930A (en) | Irradiation catheter with expandable source | |
| DE69630285T2 (en) | ULTRASOUND THERAPY DEVICE | |
| DE102005059261A1 (en) | Catheter device for the treatment of partial and / or complete vascular occlusion | |
| CN107374792A (en) | A kind of integral type layered-scaffold implanting device | |
| US20150150572A1 (en) | Dual Balloon Biliary Stone Extraction Device | |
| JPH06277294A (en) | Self-guide type catheter | |
| CN107280714A (en) | Blood vessel intervention diagnosis and therapy system | |
| JP2003502122A (en) | Radiation sources for intravascular radiation therapy | |
| CN107789719B (en) | Inner core-free thrombolysis catheter | |
| RU2297861C1 (en) | Method for carrying out transluminal laser-induced brain revascularization in atherosclerotic injury cases | |
| JPS5925762A (en) | Self-guide type cathetel | |
| JPS5930109B2 (en) | Multipurpose medical flow guide wire | |
| Papatheodorou Sr et al. | Endovascular retrieval of a detached and dislocated venous port catheter in the right heart chamber using a triple-loop snare device | |
| US6402676B2 (en) | Tip configuration for radiation source wires | |
| WO1993008864A1 (en) | Fluted catheter | |
| CN113499088B (en) | An intraluminal closure system for visualization of lower extremity varicose veins | |
| CN207575528U (en) | L head dummy cerebral angiography Multifunctional catheters | |
| CN109330636A (en) | A kind of intravascular memory metal lancing system and its application method | |
| CN207575529U (en) | J head dummy cerebral angiography Multifunctional catheters | |
| Liu et al. | Construction of a canine model with acute type B aortic dissection using a self-made pressure-driven flow device | |
| JPH06277289A (en) | Self-guide type catheter | |
| JPS612870A (en) | Medical flow guide wire and self-guide type catheter | |
| JP2005152145A (en) | Catheter for angiography | |
| Yokoi | Basics of angiography for peripheral artery disease |